Heart failure: stem cells and cardiac muscle recovery
Low ejection fraction, breathlessness and realistic goals
Quick answer
Heart failure means the heart cannot pump enough for the body's needs, commonly graded by ejection fraction. Cell research targets myocardial fibrosis and new capillary growth; reported gains tend to be in six-minute walk distance and quality of life rather than large EF jumps.
Key facts
Key metric
Ejection fraction (EF)
Trial endpoint
Six-minute walk test
Prognosis-changing drugs
RAAS, beta blocker, SGLT2
Caution
Fluid overload, arrhythmia
Guideline medication first
What actually changes prognosis in heart failure is guideline medication — RAAS inhibitors, beta blockers and newer SGLT2 inhibitors — plus salt and fluid management. Anyone not yet on optimal therapy should fix that first.
Scar tissue in the myocardium
Muscle lost to a heart attack becomes non-contracting scar. Cell studies try to limit scar expansion and improve perfusion in the surrounding zone, which is why any benefit is gradual rather than immediate.
What to prepare before travelling
If you are weighing treatment in Korea, bring your echo, ECG and current medication list for review: uncontrolled fluid overload or arrhythmia is a genuine caution for both flying and intravenous administration.
Frequently asked questions
How much can EF improve?▾
Most studies report small to moderate change, and not everyone responds.
Can heart medication stop afterwards?▾
No — only a cardiologist should adjust heart medication.
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.